Molecular control of vascular smooth muscle cell differentiation

ABSTRACT Changes in the differentiated state of the vascular smooth muscle cell (SMC) including enhanced growth responsiveness, altered lipid metabolism, and increased matrix production are known to play a key role in development of atherosclerotic disease. As such, there has been extensive interest in understanding the molecular mechanisms and factors that regulate differentiation of vascular SMC, and how this regulation might be disrupted in vascular disease. Key questions include determination of mechanisms that control the coordinate expression of genes required for the differentiated function of the smooth muscle cell, and determination as to how these regulatory processes are influenced by local environmental cues known to be important in control of smooth muscle differentiation. Of particular interest, a number of common cis regulatory elements including highly conserved CArG [CC(A/T) 6 GG] motifs or CArG‐like motifs and a TGF β control element have been identified in the promoters of virtually all smooth muscle differentiation marker genes characterized to date including smooth muscle α‐actin, smooth muscle myosin heavy chain, telokin, and SM22α and shown to be required for expression of these genes both in vivo and in vitro . In addition, studies have identified a number of trans factors that interact with these cis elements, and shown how the expression or activity of these factors is modified by local environmental cues such as contractile agonists that are known to influence differentiation of smooth muscle.